Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010566 |
---|---|
Receipt number | R000011828 |
Scientific Title | Clinical trial to evaluate the safety of Bortezomib combined with chemotherapy in children with refractory childhood acute lymphoblastic leukemia |
Date of disclosure of the study information | 2013/04/23 |
Last modified on | 2016/04/25 19:28:25 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/04/23 10:58:22 | ||
2 | Update | 2013/05/02 23:38:40 | Recruitment status |
|
3 | Update | 2013/10/23 22:08:48 | Email Division name |
|
4 | Update | 2013/10/23 22:16:50 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2013/10/23 22:19:14 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2014/05/19 17:48:32 | Basic design No. of arms Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Target sample size |
|
7 | Update | 2014/05/19 17:51:46 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2016/04/25 19:19:42 | Recruitment status |
|
9 | Update | 2016/04/25 19:24:31 | Name of primary person or sponsor Organization Category of Funding Organization |
|
10 | Update | 2016/04/25 19:28:25 | Control Interventions/Control_1 Interventions/Control_2 |